Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 16, 2021; 9(32): 9825-9834
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9825
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9825
Table 4 The progression-free survival times of patients with different systemic immune inflammation index, ratio of lymphocytes to monocytes and ratio of lymphocytes to monocytes to lactate dehydrogenase expression
Groups | Median progression free survival time | 95%CI | χ2 | P value |
SII high expression | 34 mo | 32.52-38.50 | 7.742 | 0.222 |
SII low expression | 42 mo | 39.50-46.16 | ||
LMR high expression | 35 mo | 33.42-36.58 | 8.356 | 0.004 |
LMR low expression | 43 mo | 40.64-45.36 | ||
LMR/LDH high expression | 35 mo | 33.49-36.51 | 15.163 | 0.000 |
LMR/LDH low expression | 43 mo | 40.73-45.27 |
- Citation: Wu XB, Hou SL, Liu H. Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients. World J Clin Cases 2021; 9(32): 9825-9834
- URL: https://www.wjgnet.com/2307-8960/full/v9/i32/9825.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i32.9825